Advanced kidney cancer Header
opdivo-dtc-util-nav

Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user and her son standing on a hill.
Potential OPDIVO® (nivolumab) user and her son standing on a hill.

Your fight against advanced
kidney cancer
may start or continue here

OPDIVO is an FDA-approved immunotherapy that is the foundation for three different uses in advanced kidney cancer, or renal cell carcinoma (RCC)

Actor portrayals.

Advanced kidney cancer

OPDIVO + YERVOY is a treatment option for certain adults with previously untreated kidney cancer that has spread (advanced RCC)

Advanced kidney cancer that may benefit from targeted therapy

OPDIVO, in combination with CABOMETYX® (cabozantinib), is a treatment option for certain adults with previously untreated kidney cancer that has spread (advanced RCC)

Previously treated kidney cancer

OPDIVO is a treatment option for certain adults with kidney cancer (RCC) when your cancer has spread or grown after treatment with other cancer medications

OPDIVO and OPDIVO-based combination treatments will not work for everyone. Individual results may vary.

Man exploring real patients stories of experiences with OPDIVO® (nivolumab) or other OPDIVO-based combinations.

Patient stories

Real patients share their experiences with OPDIVO and OPDIVO-based treatments

Frequently asked questions about treatment with OPDIVO® (nivolumab).

Have questions about treatment?

We have answers about infusions, monitoring, and more

Hands exploring cost information and financial help for OPDIVO® (nivolumab).

Cost information and financial help

Find information about cost and access to OPDIVO